ASTRAZENECA PLC

Organisation

1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA

Headquarters

96100

Employees

Health Technology

Industry

Pascal Soriot

AstraZeneca plc is an English pharmaceutical company located in Cambridge. It is a multinational pharmaceutical and biotechnology firm based in the United Kingdom and Sweden. 
The company operates in over 100 countries and caters to the requirements of millions of people globally. Among the significant ailments covered by the company's product range are oncology, gastrointestinal, infectious, respiratory, and inflammatory disorders.
Astra AB and Zeneca Group Plc amalgamated to establish AstraZeneca in 1999. 
Astra AB was founded in 1913 by 400 Swedish doctors. 
Zeneca Group PLC was created in 1993 when the British chemicals business ICI (formed by the amalgamation of four British chemical companies) demerged its medicines, agrochemicals, and specialist divisions to become Zeneca Group PLC.
The merger is one of the world's largest pharmaceutical businesses, having purchased several corporations, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013), and Definiens (by MedImmune in 2014). 
The organisation undertakes research and development in three strategic locations: England, Sweden, and Maryland, United States.
The Oxford–AstraZeneca vaccine was approved for use in India in January 2021, paving the way for a large-scale vaccination campaign in the world's second-most populous country. 
The Serum Institute of India later stated that the Oxford–AstraZeneca shot would be manufactured locally under the brand name COVISHIELD. Currently ASTRAZENECA PLC has a market cap of $270.68 Billion. It has a P.E ratio of 42.04. The shares of ASTRAZENECA PLC are trading at $188.93.
 .

Price

Target

ASTRAZENECA PLC (AZN) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the ASTRAZENECA PLC (AZN) share price will touch around $208.43 in next 12-months.

Currently 38 wall-street analysts regularly analyze the financials of ASTRAZENECA PLC on a frequent basis to provide recommendations along with target share price. 38 analysts offering 12-month price forecasts for ASTRAZENECA PLC (AZN) have a share price target of $208.43. This median of share price forecast represents a 13.56% upside from the latest price of $183.54 as on 23.03.26.

ASTRAZENECA PLC (AZN) Share Price Forecast

Home

US Stocks

ASTRAZENECA PLC (AZN)

ASTRAZENECA PLC Stock Forecast

ASTRAZENECA PLC Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

ASTRAZENECA PLC (AZN): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between ASTRAZENECA PLC's share price and its median forecast price. As on 23.03.26, the difference is -8.52%

ASTRAZENECA PLC Forecast and Target Price

ASTRAZENECA PLC (AZN) Share Price Forecast

ASTRAZENECA PLC (AZN) Price vs Consensus Price Target

ASTRAZENECA PLC (AZN) Share Price Forecast v/s Share Price Today

ASTRAZENECA PLC (AZN): Difference between Current Price & Median Forecasted Price

ASTRAZENECA PLC (AZN) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price